India introduces Qartemi, a cost-effective CAR-T cell therapy for B-cell Non-Hodgkin Lymphoma, offering new hope with an 83.3% success rate.

‘Did you know
About 70,000 people die every year due to #bloodcancer in India.#cancertreatment #cfdna #medindia’

About 70,000 people die every year due to #bloodcancer in India.#cancertreatment #cfdna #medindia’





Advertisement
What Makes Qartemi Special?
Unlike regular chemical-based drugs, Qartemi is a "living drug" made from the patient’s cells. The cells are taken from the patient and are genetically modified to strengthen their immune response. It is then reintroduced into the patient’s body which targets and destroys the cancer cells.Qartemi is a personalized Chimeric Antigen Receptor (CAR)-T cell therapy tailored to each patient’s condition. India reports around 1.2 lakh new blood cancer cases every year, with over 70,000 deaths. Patients with aggressive forms of B-NHL are unable to get proper treatment and cure.
Traditional treatments like chemotherapy and radiation often fail in cases of refractory blood cancer. However, Qartemi provides a new chance at survival.
Advertisement
Qartemi Clinical Trials in India
Qartemi was tested in leading hospitals like Narayana Health (Bengaluru), Apollo Cancer Hospital (Chennai), and PGIMER (Chandigarh) under the clinical trial program "IMAGINE." The results were promising, showing an 83.3% success rate in treating patients.The Indian government also supported this research through BIRAC (Biotechnology Industry Research Assistance Council). CAR-T therapy is an expensive treatment, costing up to ₹3-5 crore. But Qartemi is priced between ₹35-50 lakh, making it much more affordable for Indian patients.
Advertisement
Where Can Patients Get Qartemi?
This revolutionary therapy is now available in top hospitals across India, including:- Narayana Health
- Apollo Hospitals
- CMC Vellore & Ludhiana
- Manipal Hospitals
- Rajiv Gandhi Cancer Institute, Delhi
- SGPGI, Lucknow
- Amrita Hospital, Faridabad
Source-Medindia